ABSTRACT. Most previous studies of induced lung maturation have used fetal exposures to multiple doses of hormones, and such treatments are associated with fetal growth retardation in rodents and rabbits. This study was designed to evaluate whether single-dose maternal corticosteroid treatments could induce lung maturation without causing fetal growth retardation. Lung maturation was evaluated in 27-d gestational age rabbits by measurements of lung function after preterm delivery and ventilation. Lung function was assessed by measurements of ventilatory requirements, responses to exogenous surfactant, measurements of the recovery of intravascular albumin in the lungs, and surfactant pool sizes. As demonstrated previously, 0.1 mg/kg betamethasone (1 mg = 2.13 wmol betamethasone)
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given 48 and 24 h before delivery caused both growth retardation (birth weight 20% lower than controls, p < 0.01) and lung maturation (improved compliance, decreased radiolabeled albumin recoveries) despite lower alveolar saturated phosphatidylcholine pool sizes ( p < 0.05 versus controls). A single dose of 0.2 mg/kg betamethasone given 48 h before delivery had an equivalent effect on birth weight as the divided doses of 0.1 mg/kg betamethasone, with the only lung maturational effect being a decrease in recovery of labeled albumin in alveolar washes ( p < 0.01).
A single dose of 0.1 mg/kg betamethasone given 48 h before delivery decreased birth weight by 9.4% ( p < 0.01 versus control) but had no effect on any of the lung maturation indicators. Fetal lung maturation caused by maternal corticosteroid is associated with global fetal growth retardation, and a single low dose of corticosteroid can cause growth retardation without inducing lung maturation. The induction of lung maturation with maternal corticosteroid does not result from an isolated effect of the hormone on the fetal lung. (8), and monkeys (9) and continuous fetal infusions in sheep (10) (11) (12) . In the experimental studies and in clinical practice, multiple dosing schedules have been generally used (1, 13). However, single doses of maternal corticosteroids for intervals as short as 24 h were shown to induce surfactant proteins (14, 15) and to induce lung choline-phosphate cytidyltransferase and the adenylate cyclase system in fetal rats (16, 17) . A uniform observation in rodents is that maternal corticosteroids also cause fetal growth retardation (18) . We previously studied the hormone dose-lung maturation response relationship of two doses of corticosteroids given 48 and 24 h before delivery at 27 d gestational age in rabbits and found similar maturation responses with doses between 0.05 and 0.4 mg/kg (8) . There were no maturational effects at doses of 0.03 mg/kg and below (19) . In those studies, the lung maturation responses occurred only at corticosteroid doses that also caused fetal growth retardation in the rabbit (8, 19) . In the present studies, we asked the following questions: Would a single dose of betamethasone be as effective as the multiple-dose schedule, and could lung maturation occur without growth retardation? Functional lung maturation was evaluated after delivery of the preterm rabbits, which were ventilated to permit the assessment of several maturational responses (8, 20) . Surfactant treatments also were used to test if corticosteroid effects could be detected in lungs made surfactant-sufficient (20) .
MATERIALS A N D METHODS
Corticosteroid dosing. Time-mated pregnant rabbits were randomized to four groups and treated with intramuscular betamethasone (Celestone Soluspan, Schering Corp., Kenilworth, NJ) or vehicle control according to the schedule in Table I . The Beta 0.1 x 2 group was selected as the two-dose corticosteroid treatment regimen because the dose was relatively low and known to consistently induce a number of maturational responses in fetal rabbits without causing excessive fetal loss (8, 20) . The two single-dose schedules were selected to give either the same total dose or one half the dose received by the Beta 0.1 X 2 comparison group.
Anitnul deliver-v and ventilation. The protocols were reviewed
Corticosteroids are routinely used to induce lung maturation in fetuses at risk of preterm delivery, a clinical practice based on sound clinical trials (1). Liggins' initial description of induced lung maturation in fetal sheep resulted from studies using corticosteroid infusions (2) . Most of the early experimental studies in sheep and rabbits used direct fetal injections of corticosteroids to evaluate maturation responses (3) (4) (5) , whereas subsequent studies have generally used maternal treatments in rodents (6, 7), rabbits and approved by the Animal Care Committee at Harbor-UCLA Medical Center. Pregnant New Zealand White rabbits of known date mating to ?2 h were lightly anesthetized by a slow intravesicular infusion of pentobarbital to effect followed by spinal anesthesia using 2 mL of 2% lidocaine:0.5% bupivacaine (1 : I, vol:vol). The rabbits received oxygen via a plastic bag gently secured around the neck. The uterus was exposed, and preterm rabbits at 27 d gestational age were sequentially delivered and given 0.1 mg/kg acepromazine and 10 mg/kg ketamine by intraperitoneal injection. A tracheal tube made from an 18-gauge stainless steel needle was tied into the trachea of each rabbit. Every other rabbit in each litter received natural sheep surfactant at a weight-adjusted dose of 100 mg/kg lipid. This surfactant was recovered as previously described from the lung lavage of adult sheep (2 1). Each rabbit was ventilated with five breaths of 100% O2 using an anesthesia bag with just enough pressure to visibly move the chest. The rabbits then were moved to 37°C temperature-controlled ventilator-plethysmography systems that permitted the simultaneous measurement of ventilator pressures and integrated tidal volumes for each rabbit (22, 23) . The target tidal volumes were 8-9 mL/kg. The peak inspiratory pressures were individually adjusted to achieve the desired tidal volumes approximately every 5 min during the 30 min of ventilation. The other ventilator variables were held constant at a rate of 30 breaths/min, an inspiratory time of 1 s, a positive end expiratory pressure of 3 cm H 2 0 , and 100% oxygen. Immediately after the initiation of ventilation, the rabbits were given an external jugular vein injection of 0.2 mL 0.9% NaCl containing 1 &i '"I-labeled albumin to label the intravascular albumin (22) . Each rabbit was ventilated for 30 min, the endotracheal tube was obstructed, and the rabbit was killed with intrathecal lidocaine. After opening the chest, a blood sample was drawn from the heart for measurements of Pco~, pH, Hb, and radioactivity.
Proce.rsing qf lungs. The rabbits then had standardized lung lavages repeated 5 times with 0.9% NaCl, and the lavages were pooled for each animal (8) . The volumes were recorded and the amount of labeled albumin in each lavage was measured. The lavaged lungs were removed and weighed, and the amount of labeled albumin in the lungs was measured. The lungs then were homogenized in 0.9% NaCI, and an aliquot clarified by centrifugation was used for an Hb measurement with Drabkin's solution (24) . The amount of labeled albumin retained in the lungs was corrected for the amount of blood-associated label to yield a value for the lung tissue alone. Lipids from aliquots of the alveolar washes and lung homogenates were extracted with chloroform:methanol (2: 1) and dried under nitrogen at 50°C. The lipid extracts were treated with osmium tetroxide, and SatPC was recovered by neutral alumina column chromatography according to Mason et a/. (25) . SatPC was quantified by phosphorus assay according to Bartlett (26) .
Dula analysis. Statistical comparisons across the treatment groups were by analysis of variance with the Student-NeumanKeuls post-hoc test used to identify significant differences. Significance was accepted at p < 0.05.
RESULTS
De~cripliorr (if animals. The two groups of newborn rabbits exposed to a total dose of 0.2 mg/kg betamethasone had the same 20% decrease in body weight relative to the control rabbits ( p < 0.0 I) ( (Fig. I) . in the Beta 0.1 x 2 group relative to the control group, and there were no changes noted for the other groups.
Recovery of radiolabeled albumin. A significant surfactant effect on the percentage recovery of intravascular albumin in the total lung (alveolar wash plus lung tissue) after 30 min of ventilation was noted with a decrease in labeled albumin recovery from 4.4 f 1.9% to 1.8 f 0.8% with surfactant treatment of control animals (mean f SD) ( p < 0.01) (Fig. 3) . Although significant surfactant effects were seen in all groups, only the Beta 0.1 x 2 group demonstrated decreased albumin recoveries relative to the control group and the other corticosteroid-treated groups that were not treated with surfactant ( p < 0.01). The effect of the Beta 0.1 x 2 alone was as large as the effect of surfactant treatments in the other groups. The labeled albumin recoveries in alveolar lavages had similar patterns of recoveries with one exception. As with the total lung, surfactant decreased recoveries and Beta 0.1 x 2 decreased recoveries relative to the control and Beta 0.1 x I groups ( p < 0.01). However, the Beta 0.2 x 1 group had lower alveolar recoveries than did the control and Beta 0.1 x 1 groups ( p < 0.0 1).
DISCUSSION
The major goal of this experiment was to try to dissociate lung maturation from the fetal growth retardation effects of corticosteroids in preterm rabbits. The fact that either direct fetal injections or maternal injections of corticosteroids in rats and rabbits causes growth retardation (3) (4) (5) (6) (7) (8) means that maturational effects on the lung are not a specific targeted response of the lungs to the hormone treatment. Instead, this lung maturational response must be viewed as a global response affecting the whole fetus and as such is likely to represent a nonspecific stress response and not the specific maturational targeting of an organ. Thus, the concept that corticosteroids only trigger receptors on fetal lung fibroblasts and/or type I1 cells to induce surfactant lipid and protein components is much too simplistic when associated with growth retardation. We previously demonstrated equivalent lung maturational responses in rabbits at doses of maternal betamethasone of 0.05 to 0.4 mg/kg given 48 and 24 h after delivery of the preterm rabbits (8) . The higher doses caused higher fetal death rates but the magnitude of growth retardation and lung maturation did not change with dose. Lower doses had no effect on either growth or lung maturation (1 9).
In this experiment, the Beta 0.1 x 2 reproduced the previously There were not strong correlations indicating that lung maturation was not associated with weight within each group.
These results of variable maturational responses depend critically on dosing schedule. We were unable to achieve maturational effects resulting in improved lung function with single doses of maternal corticosteroids 48 h before delivery of the preterm rabbits. There also was no effect elicited with surfactant treatments above those detected in control animals. This functional outcome contrasts with the demonstration of increased lung enzyme levels 24 h after a single dose of maternal corticosteroid in more immature fetal rabbits (28, 29) . Oulton et a/. (27) used the different dosing strategy of giving a single dose of intraperitoneal cortisol to fetal rabbits followed by maternal thyrotropin releasing hormone to achieve maximal increases in surfactant pools. This use of multiple hormone therapies is now being evaluated in both animal models (13, 30) and in clinical trials (3 1). The maturational effects of corticosteroids in rabbits are not primarily on the surfactant system, inasmuch as alveolar SatPC pool sizes tend to decrease when they are measured after preterm delivery and a period of ventilation. Corticosteroids have multiple effects on the fetal lung structure that include increases in lung volumes (30) , changes in matrix proteins (32) , changes in lung rupture pressures (33) , changes in the alveolar surfactant pool size-compliance response curves (34) , and improved responses to surfactant treatments (20) . These results are consistent with multiple effects of the corticosteroids on the fetus that are associated with growth retardation. We think that rodent and rabbit models for studies of the mechanism of lung maturation must be interpreted cautiously because of the association of growth retardation with corticosteroid treatments.
